Choriocarcinoma: Difference between revisions
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
'''For patient information, click [[Choriocarcinoma (patient information)|here]]''' | |||
{{Infobox_Disease | | {{Infobox_Disease | | ||
Name = {{PAGENAME}} | | Name = {{PAGENAME}} | | ||
| Line 15: | Line 17: | ||
{{SI}} | {{SI}} | ||
'''Editor-in-Chief:''' Somal Khan, M.D. | '''Editor-in-Chief:''' Somal Khan, M.D. | ||
==Overview== | ==Overview== | ||
| Line 56: | Line 56: | ||
[[Hysterectomy]] (surgical removal of the uterus) can also be offered to patients > 40 years of age or those desiring sterilization. It may be required for those with severe infection and uncontrolled bleeding. | [[Hysterectomy]] (surgical removal of the uterus) can also be offered to patients > 40 years of age or those desiring sterilization. It may be required for those with severe infection and uncontrolled bleeding. | ||
{{Soft tissue tumors and sarcomas}} | {{Soft tissue tumors and sarcomas}} | ||
{{SIB}} | {{SIB}} | ||
[[Category:Gynecology]] | [[Category:Gynecology]] | ||
[[Category:Types of cancer]] | [[Category:Types of cancer]] | ||
Revision as of 19:06, 8 August 2011
For patient information, click here
| Choriocarcinoma | |
| ICD-10 | C58 |
|---|---|
| ICD-9 | 181 |
| ICD-O: | 9100-9101 |
| DiseasesDB | 2602 |
| MeSH | D002822 |
|
WikiDoc Resources for Choriocarcinoma |
|
Articles |
|---|
|
Most recent articles on Choriocarcinoma Most cited articles on Choriocarcinoma |
|
Media |
|
Powerpoint slides on Choriocarcinoma |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Choriocarcinoma at Clinical Trials.gov Trial results on Choriocarcinoma Clinical Trials on Choriocarcinoma at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Choriocarcinoma NICE Guidance on Choriocarcinoma
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Choriocarcinoma Discussion groups on Choriocarcinoma Patient Handouts on Choriocarcinoma Directions to Hospitals Treating Choriocarcinoma Risk calculators and risk factors for Choriocarcinoma
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Choriocarcinoma |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-in-Chief: Somal Khan, M.D.
Overview
Choriocarcinoma is a malignant and aggressive cancer of the placenta. It is characterized by early hematogenous spread to the lungs. It belongs to the far end of the spectrum of gestational trophoblastic diseases (GTD).
Classification of GTDs
Broadly, gestational trophoblastic diseases can be classified in the following:
- a. Complete Mole
- b. Partial Mole
2. Invasive Mole
3. Choriocarcinoma
4. Placental site trophoblastic tumor
Etiology/Epidemiology
It is preceded by:
- Hydatidiform mole (50% of cases)
- Spontaneous abortion (20% of cases)
- Ectopic pregnancy (2% of cases)
- Normal term pregnancy (20-30% of cases)
Symptoms/Signs/Labs
- increased quantitative β-hCG levels
- vaginal bleeding
- shortness of breath
- hemoptysis (coughing up blood)
- chest pain
- chest X-ray shows multiple infiltrates of various shapes in both lungs
- presents in males as a testicular neoplasm
Pathology
On light microscopy, there is malignant trophoblastic proliferation without hydropic villi.
Treatment
Choriocarcinoma is one of the tumors that is most sensitive to chemotherapy. The cure rate, even for metastatic choriocarcinoma, is around 90-95%. Virtually everyone without metastases can be cured however metastatic disease to the kidneys and/or brain is usually fatal. Chemotherapy regimen include EMACO (etoposide, methotrexate, actinomycin D, cyclosphosphamide and oncovin).
Hysterectomy (surgical removal of the uterus) can also be offered to patients > 40 years of age or those desiring sterilization. It may be required for those with severe infection and uncontrolled bleeding.